GHISELLI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 4.709
EU - Europa 2.881
AS - Asia 1.518
SA - Sud America 170
AF - Africa 124
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 9.409
Nazione #
US - Stati Uniti d'America 4.672
SG - Singapore 662
UA - Ucraina 620
IT - Italia 369
RU - Federazione Russa 346
SE - Svezia 337
IE - Irlanda 328
DE - Germania 279
TR - Turchia 264
DK - Danimarca 234
CN - Cina 216
HK - Hong Kong 205
BR - Brasile 156
FI - Finlandia 142
KR - Corea 123
FR - Francia 117
CI - Costa d'Avorio 95
GB - Regno Unito 58
MA - Marocco 24
CA - Canada 17
MX - Messico 15
BE - Belgio 14
IN - India 13
NL - Olanda 13
RO - Romania 7
IQ - Iraq 6
AR - Argentina 5
AT - Austria 5
BD - Bangladesh 5
PK - Pakistan 5
EU - Europa 4
OM - Oman 4
BG - Bulgaria 3
CL - Cile 3
IL - Israele 3
IR - Iran 3
AL - Albania 2
AZ - Azerbaigian 2
EC - Ecuador 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PS - Palestinian Territory 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IS - Islanda 1
KZ - Kazakistan 1
LV - Lettonia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
RS - Serbia 1
VE - Venezuela 1
Totale 9.409
Città #
Jacksonville 623
Chandler 568
Fairfield 442
Singapore 330
Dublin 328
Boardman 293
Ashburn 260
Wilmington 245
Woodbridge 225
Hong Kong 199
New York 188
Seattle 185
Houston 167
Ann Arbor 139
Lawrence 131
Princeton 131
San Mateo 127
Cambridge 119
Moscow 113
Abidjan 95
Des Moines 70
Turin 63
San Diego 51
Centro 49
Beijing 29
Guangzhou 21
Helsinki 20
Shanghai 20
Porto 17
The Dalles 16
Brussels 14
Los Angeles 14
Mexico City 13
Norwalk 13
Ottawa 13
Izmir 12
Pune 12
Redmond 12
Rome 11
Wuhan 11
Ancona 10
Falls Church 10
Fermo 10
Kilburn 10
London 10
São Paulo 10
Dallas 9
Munich 9
Dronten 8
Washington 8
Buffalo 7
Nuremberg 7
Jiaxing 6
Wuxi 6
Auburn Hills 5
Belo Horizonte 5
Marche 5
Brasília 4
Karachi 4
Muscat 4
North Bergen 4
Palermo 4
Rio de Janeiro 4
Shenzhen 4
Venice 4
Baghdad 3
Bologna 3
Breda Di Piave 3
Campinas 3
Campobasso 3
Chiswick 3
Chita 3
Cingoli 3
Dhaka 3
Hangzhou 3
Hounslow 3
Ivanovo 3
Nanjing 3
Osimo 3
Pescara 3
Prescot 3
San Jose 3
Turku 3
Acton 2
Aracaju 2
Auckland 2
Baku 2
Birmingham 2
Casablanca 2
Caserta 2
Cerquilho 2
Clifton 2
Conselheiro Lafaiete 2
Contagem 2
Curitiba 2
Fayetteville 2
Foligno 2
Fort Worth 2
Fuzhou 2
Guayaquil 2
Totale 5.644
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 268
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 217
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 190
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 145
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 136
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 122
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 121
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 116
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 105
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 99
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 98
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 96
Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy 96
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 90
Attività ed espressione della ossido-nitrico sintetasi nella vescica di ratti sottoposti a neuromodulazione sacrale 89
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 88
Is the bipolar vessel sealer device an effective tool in robotic surgery? A retrospective analysis of our experience and a meta-analysis of the literature about different robotic procedures by investigating operative data and post-operative course 88
Transanal endoscopic microsurgery: indications, tips and long-term results. A single center experience 87
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 86
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 85
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 85
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 84
Urinary catheters and biofilm formation 84
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 84
Anastomotic healing in a rat model of peritonitis after non-steroidal anti-inflammatory drug administration. 84
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 83
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 83
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 82
Minimally invasive approach to the adrenal gland in obese patients with Cushing’s syndrome 82
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 81
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 81
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 80
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 80
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 79
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 79
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 79
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 78
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 78
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 77
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 77
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 76
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 76
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 76
S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis. 75
Treatment of rectal cancer by transanal endoscopic microsurgery: experience with 425 patients. 74
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 74
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 74
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 74
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 74
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 73
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 73
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 73
Increase of n-NOS and i-NOS in Rat Colon After Sacral Neuromodulation 73
Efficacy of LL-37 and Granulocyte-Colony Stimulating Factor in a Neutropenic Murine Sepsis due to Pseudomonas aeruginosa 72
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 72
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 72
LL-37 protects rats against lethal gram-negative sepsis. 70
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 70
Nitric Oxide Synthase Expression in Rat Anorectal Tissue after Sacral Neuromodulation 70
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 70
The biocompatibility of dibutyryl chitin in the context of wound dressings. 70
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 70
Totally robotic vs 3D laparoscopic colectomy: A single centers preliminary experience 70
Transanal endoscopic microsurgery in the treatment of large rectal adenomas. 70
Treatment of Staphylococcus aureus Biofilm infection by the quorum sensing inhibitor RIP 69
S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis. 69
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide 68
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 68
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 67
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 66
Transanal endoscopic microsurgery as optimal option in treatment of rare rectal lesions: A single centre experience. 66
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 65
Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. 65
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 65
Robotic versus laparoscopic right colectomy for cancer: short-term outcomes and influence of Body Mass Index on conversion rate. 65
Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation 65
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 64
The bovine antimicrobial peptide BMAP-28 reduces lethality due to bacterial cell wall components in mouse models of staphylococcal sepsis 63
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 63
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 63
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 63
Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis. 62
Potential therapeutic role of cationic peptides in three experimental models of septic shock 62
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. 62
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to multiresistant Pseudomonas aeruginosa strain 61
Protective Effect of Citropin 1.1 and Tazobactam-Piperacillin Against Oxidative Damage and Lethality in Mice Models of Gram-Negative Sepsis. 61
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 61
Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation 61
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 61
Laparoscopic repair of giant Morgagni hernia by direct suturing with V-Loc. 61
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 60
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. 59
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 59
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 59
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 58
Potential therapeutic role of histatins derivative P-113D in experimental rat models of Pseudomonas sepsis 57
Therapeutic efficacy of the magainin analog MSI-78 in different intra-abdominal sepsis rat models 56
Efficacy of Tachyplesin III, Colistin and Imipenem against Multiresistant Pseudomonas aeruginosa 56
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 56
Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy 56
Totale 8.025
Categoria #
all - tutte 51.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020196 0 0 0 0 0 0 0 0 0 0 17 179
2020/20211.836 106 185 252 17 193 131 203 120 191 170 198 70
2021/20221.034 73 228 10 52 22 71 45 51 65 125 86 206
2022/20231.767 182 197 138 134 128 211 3 100 443 13 159 59
2023/2024975 175 21 59 145 168 253 17 20 5 13 14 85
2024/20251.960 283 190 131 123 104 159 249 113 455 118 35 0
Totale 9.562